|
"AT-less" Type I Polyketide Synthases
|
5R01CA106150-04
|
$281,102
|
SHEN, BEN
|
UNIVERSITY OF WISCONSIN MADISON
|
|
"Genetic interactions between Tgfb1 and Skts15/Tgfbm3 in cancer"
|
1R01CA116019-01A2
|
$295,961
|
AKHURST, ROSEMARY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
14-3-3zeta in Early Stages of Breast Cancer Progression
|
5R01CA109570-04
|
$264,158
|
Yu, Dihua
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
14-3-3zeta in ErbB2 Mediated Mammary Carcinogenesis
|
5R01CA112567-03
|
$254,494
|
Yu, Dihua
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
2006 Glycolipid & Sphingolipid Gordon Conference
|
3R13CA119831-01S1
|
$15,000
|
MERRILL, ALFRED
|
GORDON RESEARCH CONFERENCES
|
|
3D-adhesion stromagenesis in cancer permissiveness
|
5R01CA113451-02
|
$235,778
|
CUKIERMAN, EDNA
|
INSTITUTE FOR CANCER RESEARCH
|
|
4-Peroxycyclophosphamides for Brain Tumor Therapy
|
5R01CA100074-04
|
$217,702
|
STRUCK, ROBERT
|
CANCERMEDICA, LLC
|
|
A Biomagnetic Sensor for Detecting Breast Cancer
|
5R44CA096154-03
|
$593,762
|
FLYNN, EDWARD
|
SENIOR SCIENTIFIC
|
|
A Diffusion-Based MRI Method to Detect Glioma Invasion
|
1R21CA109280-01A1
|
$181,800
|
SCHMAINDA, KATHLEEN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
A flexible somatic and sporadic mouse model for pancreatic ductal adenocarcinoma
|
5R21CA120096-02
|
$179,878
|
LEWIS, BRIAN
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
A Growth-Regulating Protein Tyrosine Phosphatase
|
5R01CA058836-15
|
$376,570
|
CHERNOFF, JONATHAN
|
INSTITUTE FOR CANCER RESEARCH
|
|
A High-Throughput Model for Human Melanoma
|
1R01CA121118-01A1
|
$229,100
|
HOLMEN, SHERI
|
NEVADA CANCER INSTITUTE
|
|
A Hypersensitive ERa Mutant in Breast Cancer Progression
|
5R01CA072038-10
|
$285,759
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Mitogen-induced G Protein-coupled Receptor
|
Z01 SC 009389
|
$176,380
|
Kelly, Kathleen
|
CCR (NCI)
|
|
A mouse model for p120 downregulation in cancer
|
5R01CA111947-03
|
$287,291
|
REYNOLDS, ALBERT
|
VANDERBILT UNIVERSITY
|
|
A Mouse Model for Prostate Cancer
|
5U01CA084294-09
|
$1,212,233
|
Abate-Shen, Cory
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
A Mouse model of TGFbeta1 and ras oncogene interactions
|
5R01CA122109-02
|
$239,544
|
GLICK, ADAM
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
|
A mouse model of the zebrafish meltdown mutant
|
1R21CA120491-01A2
|
$189,000
|
PACK, MICHAEL
|
UNIVERSITY OF PENNSYLVANIA
|
|
A New Radiotracer for Sentinel Node Mapping of Colon Cancer
|
1R21CA126037-01
|
$185,400
|
HOH, CARL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
A novel biotherapeutic treatment for prostate cancer
|
1R43CA130228-01
|
$145,306
|
CHOI, ANTHONY
|
BEXION PHARMACEUTICALS, INC.
|
|
A Novel Growth Regulatory Factor in Breast Cells
|
3R01CA092440-05S1
|
$33,565
|
MONTANO, MONICA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy
|
5R01CA104035-03
|
$280,899
|
JING, NAIJIE
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Novel Oncolytic HSP Vaccine for Systemic Tumor Therapy
|
5R01CA100841-02
|
$206,823
|
HUANG, XUE
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Novel Regulator of Cancer Cell Migration and Invasion
|
5R01CA115706-02
|
$195,792
|
ALAHARI, SURESH
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
A novel set of molecular markers to measure metastatic neuroblastoma
|
5R21CA118845-02
|
$132,978
|
CHEUNG, NAI-KONG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
A Pathway of Tumor Suppression
|
5R01CA047296-20
|
$236,943
|
Lozano, Guillermina
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A Phase 2 Trial of Dasatinib in Patients with NSCLC and Acquired Resistance to Er
|
1R21CA130343-01
|
$226,200
|
MILLER, VINCENT
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
A ROLE OF MASPIN IN PROSTATE CANCER
|
3R01CA084176-05S2
|
$74,504
|
SHENG, SHIJIE
|
WAYNE STATE UNIVERSITY
|
|
A simple urinary assay for sensitive prognosis of disease progression and death f
|
1R21CA127671-01
|
$189,379
|
HILLEGONDS, DARREN
|
UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB
|
|
A Structure/function Analysis of a Tumor Specific Protein
|
1R01CA121289-01A2
|
$287,850
|
MALKAS, LINDA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
A Transgenic Model for Prostate Tumor Immunity
|
5R01CA109339-04
|
$281,848
|
ADLER, ADAM
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
A transmembrane collagen induced in prostate cancer
|
5R01CA104973-04
|
$262,798
|
ZETTER, BRUCE
|
CHILDREN'S HOSPITAL BOSTON
|
|
A Tumor Specific Therapy Approach for Small Cell Lung Cancer
|
5R21CA104297-02
|
$122,501
|
ZOU, YIYU
|
YESHIVA UNIVERSITY
|
|
Abl Kinases in growth factor signaling, motility, and invasion
|
1R01CA116784-01A2
|
$270,399
|
PLATTNER, RINA
|
UNIVERSITY OF KENTUCKY
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-32S1
|
$215,193
|
THOMPSON, CRAIG
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-32
|
$7,282,327
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
ACOSOG Central Specimen Bank
|
5U24CA114736-03
|
$555,262
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
Acoustic Radiation Force Imaging of Colorectal Tissues
|
5R01CA114075-03
|
$278,277
|
NIGHTINGALE, KATHY
|
DUKE UNIVERSITY
|
|
Acquired Resistance to VEGF blockade in Wilms tumor
|
5R01CA100451-05
|
$310,442
|
KANDEL, JESSICA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Adhesion signaling by a novel mitotic substrate of src
|
5R01CA113952-03
|
$255,337
|
MOASSER, MARK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Adhesive Regulation During Cell Migration
|
5R01CA085862-08
|
$272,882
|
HUTTENLOCHER, ANNA
|
UNIVERSITY OF WISCONSIN MADISON
|
|
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
|
3R01CA116195-03S1
|
$86,800
|
BOSLAND, MAARTEN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
|
5R01CA116195-03
|
$243,068
|
BOSLAND, MAARTEN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Adoptive T Cell Therapy of Melanoma Targeting NY-ESO-1
|
5R01CA104711-04
|
$334,292
|
YEE, CASSIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Advanced Ultrasonic Evaluation of Sentinel Lymph Nodes
|
5R01CA100183-02
|
$253,049
|
Feleppa, Ernest
|
RIVERSIDE RESEARCH INSTITUTE
|
|
AFAP-110 regulates signals that affect F-actin
|
3R01CA060731-13S1
|
$38,296
|
Flynn, Daniel
|
WEST VIRGINIA UNIVERSITY
|
|
AFAP-110 regulates signals that affect F-actin
|
5R01CA060731-13
|
$254,627
|
Flynn, Daniel
|
WEST VIRGINIA UNIVERSITY
|
|
Agents for Specific NMR and SQUID Imaging of Prostate Cancer
|
1R01CA123194-01A1
|
$493,056
|
Sillerud, Laurel
|
UNIVERSITY OF NEW MEXICO ALBUQUERQUE
|
|
Akt Intracellular Localization in Thyroid Cancer
|
5R01CA102572-03
|
$251,966
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
ALK-1 and Endoglin Signaling in Endothelial Cells
|
3R01CA105255-04S1
|
$54,505
|
BLOBE, GERARD
|
DUKE UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|